Implantable cardioverter-defibrillator therapy is indicated in all patients with ischaemic cardiomyopathy and severe systolic dysfunction: discussion
14 April 2026 (13:35 - 13:45)
Organised by: 
5 More presentations in this session
Professor C. Sticherling (Basel, CH)
Doctor J. Karvonen (Helsinki, FI)
Associate Professor G. Upadhyay (Chicago, US)
Access the full session
The Event
EHRA 2026
14 April 2026
13:35 CET
You may be interested in
Congress Session
